Aviram A - Search Results

1

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation.

Blickstein D, Aviram A, Luboshitz J, Prokocimer M, Stark P, Bairey O, Sulkes J, Shaklai M. Blickstein D, et al. Among authors: aviram a. Blood. 1997 Oct 1;90(7):2768-71. Blood. 1997. PMID: 9326244 Free article.

2

Detection of methylated ABL1 promoter in philadelphia-negative myeloproliferative disorders.

Aviram A, Witenberg B, Shaklai M, Blickstein D. Aviram A, et al. Blood Cells Mol Dis. 2003 Jan-Feb;30(1):100-6. doi: 10.1016/s1079-9796(03)00015-9. Blood Cells Mol Dis. 2003. PMID: 12667992

3

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients.

Aviram A, Blickstein D, Stark P, Luboshitz J, Bairey O, Prokocimer M, Shaklai M. Aviram A, et al. Leuk Lymphoma. 1999 Mar;33(1-2):77-82. doi: 10.3109/10428199909093727. Leuk Lymphoma. 1999. PMID: 10194123 Review.

4

Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease.

Aviram A, Rabizadeh E, Zimra Y, Yeshoron M, Marmelstein M, Shaklai M, Bairey O. Aviram A, et al. Eur J Haematol. 2000 Feb;64(2):80-4. doi: 10.1034/j.1600-0609.2000.90042.x. Eur J Haematol. 2000. PMID: 10997327

5

The role of increased calcium influx rate in receptor mediated function of differentiating HL-60 cells.

Aviram A, Rephaeli A, Shaklai M. Aviram A, et al. Cell Calcium. 1990 Apr;11(4):269-74. doi: 10.1016/0143-4160(90)90003-d. Cell Calcium. 1990. PMID: 2163284

6

Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.

Rabizadeh E, Bairey O, Aviram A, Ben-Dror I, Shaklai M, Zimra Y. Rabizadeh E, et al. Among authors: aviram a. Eur J Haematol. 2001 Apr;66(4):263-71. doi: 10.1034/j.1600-0609.2001.066004263.x. Eur J Haematol. 2001. PMID: 11380606

7

Proliferation-associated changes of Ca2+ transport in myeloid leukemic cell lines.

Rephaeli A, Aviram A, Rabizadeh E, Shaklai M. Rephaeli A, et al. Among authors: aviram a. J Cell Physiol. 1990 Apr;143(1):154-9. doi: 10.1002/jcp.1041430121. J Cell Physiol. 1990. PMID: 2180964

8

Differentiation-associated changes of cation-transport activities in myeloid leukemic cell lines.

Rephaeli A, Aviram A, Englender T, Shaklai M. Rephaeli A, et al. Among authors: aviram a. FEBS Lett. 1988 Aug 29;236(2):401-5. doi: 10.1016/0014-5793(88)80065-6. FEBS Lett. 1988. PMID: 2842190 Free article.

9

The role of calcium in differentiation of leukemic cell lines.

Rephaeli A, Aviram A, Rabizadeh E, Englender T, Shaklai M. Rephaeli A, et al. Among authors: aviram a. Cancer Biochem Biophys. 1990 Apr;11(2):119-25. Cancer Biochem Biophys. 1990. PMID: 2383856

10

Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.

Aviram A, Zimrah Y, Shaklai M, Nudelman A, Rephaeli A. Aviram A, et al. Int J Cancer. 1994 Mar 15;56(6):906-9. doi: 10.1002/ijc.2910560625. Int J Cancer. 1994. PMID: 8119779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters